These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35315015)

  • 1. The importance of β-hCG values in prediction of the effectiveness of single dose methotrexate therapy in tubal ectopic pregnancy.
    Yıldız A; Bilge O
    Ginekol Pol; 2023; 94(4):303-308. PubMed ID: 35315015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cut-off value of initial serum β-hCG level predicting a successful MTX therapy in tubal ectopic pregnancy: a retrospective cohort study.
    Helmy S; Bader Y; Pablik E; Tiringer D; Pils S; Laml T; Kölbl H; Koch M
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():175-80. PubMed ID: 24956362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early prediction of methotrexate treatment outcome in tubal ectopic pregnancy based on days 0 and 4 human chorionic gonadotropin levels.
    Shatkin Hamish N; Wolf M; Tendler R; Sharon A; Bornstein J; Odeh M
    J Obstet Gynaecol Res; 2020 Jul; 46(7):1104-1109. PubMed ID: 32406562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day 1 to day 4 serum hCG change in predicting single-dose methotrexate treatment failure for tubal ectopic pregnancies.
    Goh A; Karine P; Kirby A; Williams C; Kapurubandara S
    Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():105-110. PubMed ID: 33113399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The predictors of successful methotrexate treatment of tubal ectopic pregnancy.
    Abdelfattah-Arafa E; Abdussalam HF; Omar Saad M; El Ansari W
    J Obstet Gynaecol; 2024 Dec; 44(1):2361456. PubMed ID: 38864434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of initial and day 4 human chorionic gonadotropin levels in predicting the outcome of single-dose methotrexate treatment in women with tubal ectopic pregnancy.
    Ustunyurt E; Duran M; Coskun E; Ustunyurt ÖB; Simşek H
    Arch Gynecol Obstet; 2013 Nov; 288(5):1149-52. PubMed ID: 23666603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prediction of the success of methotrexate treatment success by 24-hour pretreatment increment in HCG and day 1-4 change in HCG.
    Levin G; Dior U; Shushan A; Gilad R; Benshushan A; Rottenstreich A
    Reprod Biomed Online; 2019 Jul; 39(1):149-154. PubMed ID: 31029556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can the Additional Dose Requirement be Determined before the Seventh Day to Successfully Treat Tubal Ectopic Pregnancy with a Single-dose Methotrexate Protocol?
    Akselim B; Karaşin SS; Sabır YA
    J Coll Physicians Surg Pak; 2021 Sep; 31(9):1046-1050. PubMed ID: 34500519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate vs expectant management for treatment of tubal ectopic pregnancy: An individual participant data meta-analysis.
    Solangon SA; Van Wely M; Van Mello N; Mol BW; Ross JA; Jurkovic D
    Acta Obstet Gynecol Scand; 2023 Sep; 102(9):1159-1175. PubMed ID: 37345445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of day 0 and day 4 β-human chorionic gonadotropin values and initial ultrasound findings in predicting the success of methotrexate treatment in ectopic pregnancy.
    Tasgoz FN; Temur M; Dundar B; Kartal E; Ustunyurt E
    Ginekol Pol; 2020; 91(7):389-393. PubMed ID: 32779159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?
    Gabbur N; Sherer DM; Hellmann M; Abdelmalek E; Phillip P; Abulafia O
    Am J Perinatol; 2006 Apr; 23(3):193-6. PubMed ID: 16586235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the change in β-hCG values between the 0th and 4th days in tubal ectopic pregnancy treatment with a single-dose methotrexate (MTX) protocol predict the need for a second dose of MTX?
    Akdaş Reis Y; Akay A; Özkan M; Fıratlıgil FB; Dereli ML; Kınay T; Erkaya S
    Arch Gynecol Obstet; 2024 Jun; 309(6):2585-2590. PubMed ID: 37493778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy.
    Nowak-Markwitz E; Michalak M; Olejnik M; Spaczynski M
    Fertil Steril; 2009 Oct; 92(4):1203-1207. PubMed ID: 18851850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidose Methotrexate Treatment of Ectopic Pregnancies with High initial β-Human Chorionic Gonadotropin: Can Success Be Predicted?
    Tug N; Sargin MA; Yassa M
    Gynecol Obstet Invest; 2019; 84(1):56-63. PubMed ID: 30099453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the parameters in predicting single-dose methotrexate therapy success for ectopic pregnancy.
    Deniz S; Ali B; Canan U; Yılmaz AH; Olcay I; Burcu D; Fatma GK
    J Obstet Gynaecol Res; 2024 May; 50(5):856-863. PubMed ID: 38476034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine β-Human Chorionic Gonadotropin Monitoring for Single-Dose Methotrexate Treatment in Ectopic Pregnancy.
    Dai Y; Zhang G; Zhu L; Lang J; Liu Z
    J Minim Invasive Gynecol; 2017; 24(7):1195-1199. PubMed ID: 28800968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors and human chorionic gonadotropin trends in patients with ruptured tubal ectopic pregnancies despite methotrexate treatment.
    Hutchinson AP; Pereira N; Chung ER; Shah NJ; Zeku M; Chung PH; Rosenwaks Z
    Gynecol Endocrinol; 2019 Jan; 35(1):49-52. PubMed ID: 30322280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy.
    Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R
    Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of early determination of β-human chorionic gonadotropin levels in predicting the success of single-dose methotrexate treatment in ectopic pregnancy.
    Çelik H; Tosun M; Işık Y; Avcı B
    Ginekol Pol; 2016; 87(7):484-7. PubMed ID: 27504939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the success rates of a single dose and an additional dose of methotrexate on the 4th day in patients whose β-hCG values do not fall after a single dose of methotrexate (Day 0-4).
    Agbal T; Erturk Aksakal S; Pay RE; Erkaya S
    J Gynecol Obstet Hum Reprod; 2024 Oct; 53(8):102811. PubMed ID: 38844087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.